investment.com

Oruka Therapeutics, Inc. — insider transactions

18 transactions on record · ORKA · CIK 907654

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
18
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$2.3M
Median disclosure lag
0.5 d
trade date to filing date
Largest single trade, 24m
$480.2K
2026-07-13
Director share, 12m
0.0%
of transactions where role is stated
Current run
18 sells
consecutive same-direction transactions
Net 3m flow
-$2.3M
purchases minus sales
Total on record
18

Transactions

18 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-212026-09-210Agarwal ArjunSenior Vice President, FinanceOpen market sale533$95.75$51Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceOpen market sale2,100$104.67$219.8Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceOpen market sale2,142$107.71$230.7Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,542$12.50$106.8Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceOpen market sale2,132$105.57$225.1Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceOpen market sale2,358$108.46$255.8Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$34.39$50.1Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceOpen market sale1,268$106.63$135.2Kfiling
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,542$0.00—filing
2026-08-142026-08-131Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$0.00—filing
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$34.39$50.1Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale5,656$84.90$480.2Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative1,458$0.00—filing
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,541$12.50$106.8Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale3,743$84.26$315.4Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceExercise of derivative8,541$0.00—filing
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale300$83.07$24.9Kfiling
2026-07-132026-07-130Agarwal ArjunSenior Vice President, FinanceOpen market sale300$85.63$25.7Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Oruka Therapeutics, Inc. insider transactions — 18 filings on record — investment.com